Csenge Advisory Group’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,515	Closed	-$325K	–	722
2024 Q2	$325K	Sell	3,515 -14	-0.4%	-$1.24K	0.02%	506
2024 Q1	$337K	Sell	3,529 -381	-10%	-$32K	0.02%	519
2023 Q4	$298K	Sell	3,910 -2,429	-38%	-$169K	0.02%	522
2023 Q3	$439K	Sell	6,339 -2,679	-30%	-$215K	0.03%	398
2023 Q2	$851K	Buy	9,018 +546	+6%	+$47.5K	0.06%	245
2023 Q1	$701K	Buy	8,472 +51	+0.6%	+$4.01K	0.05%	268
2022 Q4	$628K	Sell	8,421 -306	-4%	-$23.6K	0.05%	294
2022 Q3	$721K	Buy	8,727 +454	+5%	+$43.7K	0.06%	263
2022 Q2	$787K	Sell	8,273 -107	-1%	-$11.1K	0.07%	252
2022 Q1	$986K	Buy	8,380 +1,086	+15%	+$122K	0.08%	222
2021 Q4	$764K	Sell	7,294 -458	-6%	-$53.4K	0.07%	251
2021 Q3	$870K	Buy	7,752 +458	+6%	+$52.3K	0.07%	245
2021 Q2	$764K	Buy	7,294 +4,301	+144%	+$405K	0.07%	252
2021 Q1	$257K	Sell	2,993 -98	-3%	-$8.29K	0.03%	419
2020 Q4	$282K	Sell	3,091 -75	-2%	-$6.22K	0.03%	343
2020 Q3	$249K	Sell	3,166 -55	-2%	-$4.29K	0.03%	330
2020 Q2	$223K	Buy	+3,221	New	+$229K	0.03%	329
2018 Q4	–	Sell	-417	Closed	-$20K	–	591
2018 Q3	$20K	Sell	417 -3,900	-90%	-$191K	0.01%	392
2018 Q2	$211K	Buy	+4,317	New	+$201K	0.08%	236